Metastatic retroperitoneal lymphadenopathy for colorectal cancer is primarily treated with systemic chemotherapy. Highly selected patients may benefit from operative retroperitoneal lymph node dissection, and/or may considered for ablative radiation treatment. In this Virtual Tumor Board, we will review these considerations through case-based presentations including a multi-disciplinary panel of surgeons, medical and radiation oncologists.
- Provider:Society of Surgical Oncology
- Activity Link: https://experted.surgonc.org/Public/Catalog/Details.aspx?id=deQxD5Gng0kaE1KDDOFETw%3d%3d&returnurl=%2fUsers%2fUserOnlineCourse.aspx%3fLearningActivityID%3ddeQxD5Gng0kaE1KDDOFETw%253d%253d
- Start Date: 2024-09-16 05:00:00
- End Date: 2024-09-16 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: No
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Complex General Surgical Oncology
Subscribe
Login
0 Comments
Oldest